According to the US embassy in Nigeria, the latest outbreak of monkeypox in the country has nothing to do with it.
It stated that the US government has continued to provide technical assistance; and financing to Nigerian health officials in order to combat disease outbreaks such as COIVD-19 and monkeypox, among others.
Temitayo Famutimi, an Information Specialist at the US Consulate General’s Public Affairs Section, announced this in a statement on Monday, May 30.
The declaration was made in response to allegations that the US government was spreading monkeypox disease in Nigeria by employing laboratories under its control.
Rather of spreading diseases, the US government has aided the Nigerian health sector in the areas of capacity building, equipment, commodities/consumables; and finance to essential public health programmes, hospitals, and laboratories, according to the statement.
Since the beginning of the year 2022, Nigeria has experienced its first death from monkeypox sickness.
The Nigeria Centre for Disease Control (NCDC) verified the death; and said 21 cases have been reported in the last five months from nine states and the Federal Capital Territory (FCT).
Part of the statement read; “Recent misleading posts on social media wrongly speculate on the origin of the current global outbreak of monkeypox disease, and supposedly call for WHO to investigate so-called “U.S.-controlled laboratories” in Nigeria.
“Such reports are pure fabrication. There is zero merit to any allegations regarding the use of U.S.-assisted Nigerian laboratories in the spread of monkeypox. Furthermore, there are no “U.S.-controlled” laboratories in Nigeria.
“These falsehoods detract from the work that the United States, in close coordination with Nigerian and multilateral partners, accomplished together on public health, including in disease surveillance, diagnosis, prevention, and control.
“The collaborative work between Nigeria and the United States has provided opportunities for technical assistance in capacity building, equipment, commodities/consumables, and funding to critical public health programmes, hospitals and laboratories. All of this contributes greatly to the prevention and amelioration of global disease outbreaks.”